Références

1. Anonymus. Magnesium Natura Foundation. 
2. Rude RK. Magnesium. In Modern Nutrition Handbook in Health and Diseases. Wolters Kluwers 2016; 11the ed.
3. Guerrera MP et al. Therapeutic uses of magnesium. American family Physician. 2009; 80 (2): 157-162.
4. Anonymus. Magnesium Homeostasis. in Martindale on Medicines Complete online database. VUB 2016. 
5. Ranade VV & Somberg JC. Bioavailability and pharmacokinetics of magnesium after administration of magnesium salts to humans. American Journal of therapeutics 2001; 8: 345-357
6. Leemans L. Verschillen in biologische beschikbaarheid en tolerantie van magnesiumzouten…Much ado about nothing….. Medi-Sfeer 2016; nr. 513. 
7. Pardo MR et al. Bioavailability of magnesium food supplements: A systematic review. Nutrition 2121; 89: 111294.
8. Kyselovic J. et al. A New Caco-2 Cell Model of in Vitro Intestinal Barrier: Application for the Evaluation of Magnesium Salts Absorption. Physiol. Res. 2021; 70 (Suppl. 1): S31-S41.
9. Werner T. et al. Assessment of bioavailability of Mg from Mg citrate and Mg oxide by measuring urinary excretion in Mg-saturated subjects. Magnesium Research 2019; 32 (3): 63-71.
10. Steward CJ. et al. One week of magnesium supplementation lowers IL-6, muscle soreness and increases 1 post exercise blood glucose in response to downhill running. European Journal of Applied Physiology 2019; 119:2617–2627.
11. Hefferman SM et al. The Role of Mineral and Trace Element Supplementation in Exercise and Athletic Performance: A Systematic Review. Nutrients 2019, 11, 696; doi:10.3390.
12. Veronese N. et al. Effect of oral magnesium supplementation on physical performance in healthy elderly women involved in a weekly exercise program: a randomized controlled trial. Am J Clin Nutr 2014; 100: 974–81.
13. Topf JM & Murray PT. Hypomagnesia and Hypermagnesemia. Reviews in Endocrine & Metabolic Disorders 2003; 4: 195-206.
14. Anonymus. PPIs en hypomagnesie. Folia Farmacotherapeutica 2013; 40: p.61. 
15. Jannett S. et al. Hypomagnesemia Induced by Long-Term Treatment with Proton-Pump Inhibitors. Gastroenterology Research and Practice Volume 2015, Article ID 951768, 7 pages.
16. Wei Tatt Jo et al. Hypomagnesaemia associated with long-term use of proton pump inhibitors. Gastroenterology Report 2015;3: 243–253.
17. Atkinson NS et al. ‘Lemonade Legs’: Why do Some Patients Get Profound Hypomagnesaemia on Proton-Pump Inhibitors? Intest Res 2015; 13(3): 227-232.
18. Cundy T. & McKay J. Proton pump inhibitors and severe hypomagnesaemia. Current Opinion in Gastroenterology 2011, 27:180–185.
19. Asbaghi O. et al. The Effects of Magnesium Supplementation on Lipid Profile Among Type 2 Diabetes Patients: a Systematic Review and Meta-analysis of Randomized Controlled Trials. Biological Trace Element Research 2021; 199:861–873.
20. Piuri G. et al. Magnesium in Obesity, Metabolic Syndrome, and Type 2 Diabetes - Review. Nutrients 2021, 13, 320. https://doi.org/10.3390/nu13020320.
21. Rosanoff A. et al Effectively Prescribing Oral Magnesium Therapy for Hypertension: A Categorized Systematic Review of 49 Clinical Trials. Nutrients 2021, 13, 195. https://doi.org/10.3390/nu13010195.
22. Zamani M. & Haghighat N. The Effects of Magnesium Supplementation on Serum Magnesium and Calcium Concentration in Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Clin Nutr Res. 2022 Apr;11(2):133-145.
23. Veronese N. et al. Oral Magnesium Supplementation for Treating Glucose Metabolism Parameters in People with or at Risk of Diabetes: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials. Nutrients 2021, 13, 4074. https://doi.org/10.3390/nu13114074.
24. Mah J. & Pitre T. Oral magnesium supplementation for insomnia in older adults: a Systematic Review & Meta-Analysis. Mah and Pitre BMC Complementary Medicine and Therapies (2021) 21:125 https://doi.org/10.1186/s12906-021-03297-z.
25. Arab A. et al. The Role of Magnesium in Sleep Health: a Systematic Review of Available Literature. Biological Trace Element Research. https://doi.org/10.1007/s12011-022-03162-1.
26. Botturi A. et al. The Role and the Effect of Magnesium in Mental Disorders: A Systematic Review. Nutrients 2020, 12, 1661; doi:10.3390/nu12061661.
27. Groenendijk I. et al. Impact of magnesium on bone health in older adults: A systematic review and meta-analysis. Bone 2022; 154: 116-233.
28. Kyselovic J. et al. A New Caco-2 Cell Model of in Vitro Intestinal Barrier: Application for the Evaluation of Magnesium Salts Absorption. Physiol. Res. 2021; 70 (Suppl. 1): S31-S41.
29. Mühlbaer B. et al. Magnesium-L-aspartate-HCI and magnesium-oxide: bioavailability in healthy volunteers. Eur J Clin Pharmacol 1991; 40: 437-438.
30. Walker AF. et al. Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study. Magnesium Research 2003; 16 (3): 183-191.
31. Werner T. et al. Assessment of bioavailability of Mg from Mg citrate and Mg oxide by measuring urinary excretion in Mg-saturated subjects. Magnesium Research 2019; 32 (3): 63-71.
32. Firoz M. & Graber M. Bioavailability of US commercial magnesium preparations. Magnesium Research 2001, 14 (4): 257-262.
33. Ivanovic N. et al. Effects of short-term magnesium supplementation on ionized, total magnesium and other relevant electrolytes levels. Biometals 2022; 35:267–283.
34. Rooney MR et al. Circulating Ionized Magnesium: Comparisons with Circulating Total Magnesium and the Response to Magnesium Supplementation in a Randomized Controlled Trial. Nutrients 2020, 12, 263; doi:10.3390/nu12010263.

Numéro d’approbation

MAT-BE-UNBRANDED-24-000040
P&G Health Belgium BV/SRL Temselaan 100, 1083 Strombeek-Bever (05/2024)